CAPR Latest Headlines

Capricor's $150 Million Offering Signals Strategic Shift for DMD Therapeutics Development

Market Chameleon (Mon, 8-Dec 11:14 AM)

Capricor’s $150 Million Offering Poised to Accelerate Cell Therapy Development for Rare Diseases

Market Chameleon (Fri, 5-Dec 7:06 AM)

Capricor's HOPE-3 Study Delivers 54% Slowing of Disease Progression in Duchenne Muscular Dystrophy—Key Endpoints Achieved

Market Chameleon (Thu, 4-Dec 10:41 AM)

Capricor’s HOPE-3 Results Show 54% Slowing of Disease Progression in Duchenne Muscular Dystrophy

Market Chameleon (Wed, 3-Dec 10:28 AM)

HOPE-3 Trial Results Point to Deramiocel’s Impact on Duchenne Muscular Dystrophy Progression and Cardiac Health

Market Chameleon (Wed, 3-Dec 7:30 AM)

Capricor Unveils Scalable Framework for Loading Therapeutic Oligonucleotides into Exosomes—Potential Leap Forward for Clinical Manufacturing

Market Chameleon (Mon, 24-Nov 9:16 AM)